Changes in plasma protein binding have little clinical relevance

被引：575

作者：

Benet, LZ ^{[1
]}

Hoener, BA ^{[1
]}

机构：

[1] Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2002年 / 71卷 / 03期

关键词：

D O I：

10.1067/mcp.2002.121829

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：115 / 121

页数：7

共 20 条

[1] POTENTIATION OF ANTICOAGULANT EFFECT OF WARFARIN BY PHENYLBUTAZONE [J].

AGGELER, PM ;

OREILLY, RA ;

LEONG, L ;

KOWITZ, PE .

NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (09) :496-&

[2] PHENYLBUTAZONE-WARFARIN INTERACTION IN MAN - FURTHER STEREOCHEMICAL AND METABOLIC CONSIDERATIONS [J].

BANFIELD, C ;

OREILLY, R ;

CHAN, E ;

ROWLAND, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) :669-675

[3]

CHRISTENSEN LK, 1963, LANCET, V2, P1298

[4]

FOX SL, 1964, JAMA-J AM MED ASSOC, V188, P320

[5]

Gilman, 1996, GOODMAN GILMANS PHAR, P1707

[6] UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].

HOLFORD, NHG ;

SHEINER, LB .

CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453

[7]

HOLFORD NHG, 1995, BASIC CLIN PHARM, P33

[8] PROTEIN-BINDING DRUG DISPLACEMENT INTERACTIONS - FACT OR FICTION [J].

MACKICHAN, JJ .

CLINICAL PHARMACOKINETICS, 1989, 16 (02) :65-73

[9] PLASMA-PROTEIN BINDING DISPLACEMENT INTERACTIONS - WHY ARE THEY STILL REGARDED AS CLINICALLY IMPORTANT [J].

ROLAN, PE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (02) :125-128

[10] CLEARANCE CONCEPTS IN PHARMACOKINETICS [J].

ROWLAND, M ;

BENET, LZ ;

GRAHAM, GG .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (02) :123-136

← 1 2 →